Episode

Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Podcast: Lung Cancer Update
Published: Oct 20, 2025
Duration seconds: 1487
Processing state: not_requested
Canonical source: https://lung-cancer-update.captivate.fm/episode/5551-5mjc2025-trop2lung-3
Audio: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/838baf77-70da-4f36-bd48-5bbe16f020f6.mp3
JSON: /v1/public/podcasts/lung-cancer-update-827388/episodes/lung-cancer-5-minute-journal-club-issue-3-with-dr-aaron-lisberg-defining-the-role-of-trop2-directed-antibody-drug-conjugates
Markdown: /podcast/lung-cancer-update-827388/lung-cancer-5-minute-journal-club-issue-3-with-dr-aaron-lisberg-defining-the-role-of-trop2-directed-antibody-drug-conjugates.md

Actions

POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/lung-cancer-5-minute-journal-club-issue-3-with-dr-aaron-lisberg-defining-the-role-of-trop2-directed-antibody-drug-conjugates/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/lung-cancer-update-827388/lung-cancer-5-minute-journal-club-issue-3-with-dr-aaron-lisberg-defining-the-role-of-trop2-directed-antibody-drug-conjugates.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.  CME information and select publications here .